Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases

This publication has 9 references indexed in Scilit:

• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma
  International Journal of Cancer, 1997
• Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
  Blood, 1996
• T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
  British Journal of Haematology, 1995
• Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
  The Journal of Immunology, 1994
• Use of Recombinant Human Interleukin-2 in Conjunction with Bone Marrow Transplantation as a Model for Control of Minimal Residual Disease in Malignant Hematological Disorders: I. Treatment of Murine Leukemia in Conjunction with Allogeneic Bone Marrow Transplantation and IL-2-Activated Cell-Mediated Immunotherapy
  Cancer Investigation, 1992
• New developments in bone marrow transplantation
  Current Opinion in Oncology, 1991
• Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI)
  Cancer Immunology, Immunotherapy, 1981
• Spontaneous murine B-cell leukaemia
  Nature, 1978